Schema, ETL, queries, internal tooling. Postgres and a well-scoped service will do the job faster, cheaper, with better guarantees than any LLM.
A read on where AI fits in Florida's life sciences stack. And where it does not.
A short brief on what a defensible AI orchestration methodology would look like inside your member companies' FDA-regulated pipelines, and how it could slot into the Workforce Development program, the chapter cadence, and the 2027 conference agenda.
The narrow question on this page
BioFlorida speaks for 8,600 establishments and roughly 107,000 Floridians working in BioPharma, MedTech, Digital Health, and Health Systems. The annual Innovation Conference runs October 14 to 16 in Orlando. The Workforce Development program runs out of J&J's Tampa facility. Seven chapters stretch from Gainesville down to Miami.
The question on this page is narrow. What role can a defensible AI orchestration methodology play inside your member companies' FDA-regulated pipelines, and where can BioFlorida position that methodology inside its existing program cadence.
Most organizations pay for AI infrastructure they do not need.
Our working split across 30-plus engagements. When a team calls something an "AI problem," this is usually what is actually inside.
Workflow routing, deterministic decision trees, document classification with known vocabularies. A properly scoped orchestration layer handles this.
Language models, vision, probabilistic reasoning where deterministic logic cannot hold. For biotech and medtech, this 10% is where the regulatory risk lives.
The workforce-scale pattern, adapted for regulated industry.
Since May 2025 we have trained 1,500-plus people across enterprise engagements, including Pacific Life and Colgate-Palmolive, through a workforce enablement delivery partner called Correlation One. Measured results across those engagements:
The delivery pattern is cohort training with a live methodology handoff. Each participant walks out with the orchestration framework their team can use the following Monday, not a deck and a recording.
A Florida member-company version would be adapted for regulated-industry documentation: GxP-aware examples, FDA-defensible process design, device software (SaMD) considerations, and IRB / HIPAA-aware handling of clinical text. That is the version that maps to BioFlorida's Workforce Development track and to the chapter program cadence.
Secondary reference if it comes up: KPMG UK, one of the Big Four, 40-plus executives trained in a regulated-industry, leadership-level setting. Use it as the compliance-sensitive leadership analog.
Correlation One delivery partner. Pacific Life, Colgate-Palmolive cohorts. Program references available on request.
Ethics Engine: the paper that reads as defensible at the compliance level.
The Ethics Engine is a psychometric assessment tool for evaluating ideological and moral patterns in large language models. Published on arXiv and open-sourced on GitHub. For a medtech General Counsel or a biopharma Chief Compliance Officer reading the materials before a board conversation, this is the work that will land.
It is the defensibility anchor for a methodology delivered to FDA-regulated member companies. The companion methodology, Interpretable Context Methodology (ICM), is submitted to ACM TiiS and is what gets delivered in the room. Ethics Engine is the paper that gets past the regulatory filter at the board level. One paper per prospect. For BioFlorida, this is the right pick.
Read either link directly before any next conversation. The arXiv preprint is the short read. The GitHub repository is the implementation.
Who is proposing this, and why a regulated-industry room should read it.
Jake Van Clief, Founder & CEO, Eduba
- Marine Corps veteran. Eight years in cryptographic systems and F-35 / F-18 avionics.
- MSc Future Governance, University of Edinburgh.
- Published in ACM TiiS (ICM methodology) and arXiv (Ethics Engine).
- 1,500-plus people trained across enterprise engagements since May 2025.
How to read the military background
The Marine Corps work is context, not a marketing angle. In a regulated-industry audience it reads as the trust signal it is meant to be: the instinct to document a process so it can be audited later comes from eight years of doing exactly that on aircraft that cannot afford ambiguity.
That is the instinct BioFlorida's member companies need when moving AI into GxP, SaMD, or clinical-data pipelines. The methodology is defensible because it is built that way, not because of the talk around it.
Thirty minutes with our CRO. Calendar link at the right.
Bring one workflow inside a member company that you wish ran faster and holds up in a GxP audit. We will walk it through the 60 / 30 / 10 frame and decide what, if any, program shape fits the 2026 and 2027 calendar.
If a workforce-track pilot is the right starting point, we scope that. If a chapter cycle across Tampa Bay, Southeast, and Palm Beach / Treasure Coast is the better fit, we scope that instead. If neither fits right now, that is also a clean answer and the thirty minutes are still worth the call.